Arrowhead Pharmaceuticals Corp (ARWR) Reports In-Line Q3 EPS, Revenues Beat
Go back to Arrowhead Pharmaceuticals Corp (ARWR) Reports In-Line Q3 EPS, Revenues Beat| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 85.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.59 | 52 Week High | $8.22 | |||
| Open | $85.59 | 52 Week Low | $3.07 | |||
| Day High | $85.59 | P/E | N/A | |||
| Day Low | $85.59 | EPS | $-1.30 | |||
| Volume | 3 | |||||
